News
The SVP of educational development’s contribution to the book displays SKNV’s approach to furthering education and ...
Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...
Health services company Humana announced its first Humana Cognitive Games. 1 The event is designed to give older adults both ...
Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...
The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...
Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...
Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication ...
Corina Dutcus, SVP, oncology global clinical development lead, Eisai, explains how E7386 and lenvatinib work together to ...
The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on ...
Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...
Sun Pharmaceutical Industries, announced its release of Leqselvi in the U.S. earlier this week. Leqselvi™ is currently ...
A Harvard Business School Healthcare Alumni Association Q&A with Dr. Henry A. McKinnell, former Chairman and CEO of Pfizer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results